HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...

Whereas the new HIV prevention drug, Lenacapavir, is a positive step towards HIV prevention, its cost is prohibitive. The ...

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...

While PrEP tablets are already prescribed around the world to prevent people from contracting HIV, experts in the US hope a newly approved jab could improve rates of protection.

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...

Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") ...

From digging into President Donald Trump’s ongoing battle with the courts to deciding whether people can be required to ...